Please login to the form below

DEMAND DIVERSITY REPORT 02: Why is the LGBTQ+ community facing poorer health outcomes due to COVID-19?

We’re all aware that clinical trials have been discussed more widely since the COVID-19 pandemic. While that’s a great thing for raising awareness of clinical trials in general, it’s also highlighted some pretty big issues in clinical research. For example, the world can see how the BAME community has been disproportionately affected by the coronavirus, which has also underlined how unrepresentative clinical trials are of them. And over the last few weeks, we’ve been looking at other populations who are also being left behind.

The LGBTQ+ community have faced a history of marginalisation in clinical trials, leading to challenges and barriers that still deter them from taking part. According to research from the LGBT Foundation, LGBTQ+ people are:

  • Less likely to access healthcare when they need it
  • More likely to be living with HIV
  • More likely to be homeless or insecurely housed
  • More likely to smoke
  • Less likely to be physically active or have a good diet

And as we began to look into the relationship between the LGBTQ+ community and clinical trials via social listening, we’ve seen that individuals face poorer health outcomes as a result of COVID-19…

Insights into the LGBTQ+ community and clinical trials

Of all the online content that we audited, we found it shocking that only 2% was positive, while the other 98% was neutral or negative. Just to give you an idea of what we mean, the most frequently occurring keywords associated with terms like ‘LGBTQ+’ and ‘clinical trials’ are predominantly negative and medical terms such as: “Undiagnosed HIV infection” and “Heart disease risk” - as well as talk around key evidence gaps, donor eligibility and lifestyle factors including diet, alcohol and recent sex.

Traditionally, members of the LGBTQ+ community have been seen as hard‐to‐reach populations for clinical trial recruitment due to historical stigmatisation. Only a decade ago, a review of the inclusion criteria in clinical trials indicated that exclusion of lesbians and gay men from clinical trials in the US isn’t uncommon, particularly in studies with sexual function as an end point. And another study found women were underrepresented in research in 7 out of the 11 disease categories, even when women were more likely to have the disease.

Fast forward to 2020, and COVID-19 clinical trial guidelines are being called out as demonstrating “archaic and homophobic rules” that prevent gay and bisexual men from participating due to blood and plasma donation guidance.

In light of this, our social listening report looks deeper into how LGBTQ+ people still face discrimination and stark health inequalities rooted in historical preconceptions. Plus, we highlight how clinical research will need to address these issues during and following the COVID-19 pandemic.

You can read the full report here:

Downloads

  LGBTQ+ and Clinical Trials
PDF File: 657.2 KB

13th July 2020

Downloads

  LGBTQ+ and Clinical Trials
PDF File: 657.2 KB

Share

Tags

Company Details

COUCH Health

+44 (0) 330 995 0656

Contact Website

Address:
Suite 2.10, Jactin House
24 Hood Street
Manchester
M4 6WX
United Kingdom

Latest content on this profile

Overcoming the digital patient recruitment challenges of connecting with patients
How many irrelevant experiences, ads, emails, direct messages have you rejected this week?
COUCH Health
Clinical trial design and how it can be used to improve the patient experience
For this article, we want to go back to basics and describe the main features of the most commonly used designs for clinical trials, why they are set-up in this way, and how they can be used to benefit the patient experience.
COUCH Health
What to do and what to avoid when writing about ethnicity
It’s always important to talk about ethnicity, especially when it comes to talking about diversity in clinical trials. It’s also important to know how to talk about ethnicity too. So, we’ve made you a step-by-step guide on what you should and shouldn’t do when talking and writing about ethnicity. Let’s get stuck in.
COUCH Health
Is your clinical trial method tried and tested with patients in mind?
As you may know, we talk about putting patients first, a lot. This means thinking about patients when discussing, writing and designing recruitment materials, whilst also using a multi-method approach. For example, there are huge benefits in using direct patient insights from advocacy groups, as well as conducting social listening exercises. If you utilise these approaches, you’re more likely to engage with the patient population as effectively as possible. This is what creates successful patient recruitment strategies. Makes sense, right?
COUCH Health
Clinical trial branding: 5 reasons it’s important to your clinical trials
Your clinical trial is one of hundreds of thousands enrolling patients at any given time. You’ve got to ask yourself, what makes my study different? Why enrol in my study?
COUCH Health
Key benefits of a digital patient recruitment solution
Why should you choose COUCH Health and our new digital patient recruitment software - TrialVerse?
COUCH Health